IMPlementation of gUideLines for the Management of Arterial hypertenSION. The IMPULSION Study

NCT00416611 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1000

Last updated 2009-01-29

No results posted yet for this study

Summary

The objective of this protocol is to improve awareness, treatment, and control of arterial hypertension, within primary prevention of target organ damage, by implementing guidelines, after training of the participating physicians.

Conditions

Interventions

BEHAVIORAL

Implementation of guidelines

Sponsors & Collaborators

  • Hellenic Atherosclerosis Society

    lead OTHER

Principal Investigators

  • Athyros G Athyros, MD · Clinical Trials Chair of Hellenic Atherosclerosis Society

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-11-30
Primary Completion
2007-11-30
Completion
2007-11-30

Countries

  • Greece

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00416611 on ClinicalTrials.gov